Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunovant Inc
(NQ:
IMVT
)
28.74
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20
Open
28.74
Bid (Size)
28.50 (6)
Ask (Size)
35.70 (1)
Prev. Close
28.74
Today's Range
28.74 - 28.74
52wk Range
15.39 - 45.58
Shares Outstanding
114,998,871
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
March 25, 2024
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Via
InvestorPlace
Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
March 21, 2024
Investors saw Chugai's experimental drug as a potential rival to Argenx's approved medicine, Vyvgart.
Via
Investor's Business Daily
Performance
YTD
-30.56%
-30.56%
1 Month
-7.94%
-7.94%
3 Month
-28.22%
-28.22%
6 Month
-14.97%
-14.97%
1 Year
+80.30%
+80.30%
More News
Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
February 26, 2024
Via
InvestorPlace
Recap: Immunovant Q3 Earnings
February 12, 2024
Via
Benzinga
Argenx Dives On Autoimmune Therapy Failure
December 20, 2023
Via
Investor's Business Daily
Analyst Ratings for Immunovant
December 01, 2023
Via
Benzinga
Where Immunovant Stands With Analysts
November 15, 2023
Via
Benzinga
Recap: Immunovant Q2 Earnings
November 09, 2023
Via
Benzinga
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
February 06, 2024
Via
InvestorPlace
3 Top-Rated Russell 2000 Stocks Wall Street Analysts Are Loving Now: January 2024
January 19, 2024
Via
InvestorPlace
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
Via
The Motley Fool
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
December 22, 2023
Via
Investor's Business Daily
The Latest Analyst Ratings for Immunovant
October 09, 2023
Via
Benzinga
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Via
Benzinga
Immunovant Scores Much-Needed Win Following Argenx-Led Sell-off
December 21, 2023
Via
Investor's Business Daily
Autoimmune Disease Player Immunovant's Investigational Drug For Immune System Disorder Shows Response Rates Of Over 50%
December 21, 2023
Via
Benzinga
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
December 21, 2023
Via
Benzinga
Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
December 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From
Roivant Sciences
Via
GlobeNewswire
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
Via
Benzinga
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
December 01, 2023
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
November 28, 2023
From
Roivant Sciences
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
October 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.